Let's hope the next ones are done at better Ts&Cs. If they really talk to Big Pharma, which was mentioned that way for the first time on Friday, then we should get a re-rate soon. It is all about data and those ones are mind blowing compared to the competition. But using IMU as an example, even its CF33's incredible performance hasn't seen any official Big Pharma interest. Maybe we all have to wait for the NEU-effect, running when an FDA approval is close / imminent / granted. That would be a mirrored L-rise, ideal for holders like me but not for the majority of small and big investors who wants to see a steady gradual increase, like 30 to 45 degree over time.
GLTA
CHM Price at posting:
2.8¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)